UNIGE document Scientific Article
previous document  unige:84845  next document
add to browser collection
Title

Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications

Authors
Kumar Vr, Santhosh
Darisipudi, Murthy N
Steiger, Stefanie
Devarapu, Satish Kumar
Tato, Maia
Kukarni, Onkar P
Mulay, Shrikant R
Thomasova, Dana
show hidden authors show all authors [1 - 24]
Published in Journal of the American Society of Nephrology. 2016, vol. 27, no. 6, p. 1635-49
Abstract Endothelial dysfunction is a central pathomechanism in diabetes-associated complications. We hypothesized a pathogenic role in this dysfunction of cathepsin S (Cat-S), a cysteine protease that degrades elastic fibers and activates the protease-activated receptor-2 (PAR2) on endothelial cells. We found that injection of mice with recombinant Cat-S induced albuminuria and glomerular endothelial cell injury in a PAR2-dependent manner. In vivo microscopy confirmed a role for intrinsic Cat-S/PAR2 in ischemia-induced microvascular permeability. In vitro transcriptome analysis and experiments using siRNA or specific Cat-S and PAR2 antagonists revealed that Cat-S specifically impaired the integrity and barrier function of glomerular endothelial cells selectively through PAR2. In human and mouse type 2 diabetic nephropathy, only CD68(+) intrarenal monocytes expressed Cat-S mRNA, whereas Cat-S protein was present along endothelial cells and inside proximal tubular epithelial cells also. In contrast, the cysteine protease inhibitor cystatin C was expressed only in tubules. Delayed treatment of type 2 diabetic db/db mice with Cat-S or PAR2 inhibitors attenuated albuminuria and glomerulosclerosis (indicators of diabetic nephropathy) and attenuated albumin leakage into the retina and other structural markers of diabetic retinopathy. These data identify Cat-S as a monocyte/macrophage-derived circulating PAR2 agonist and mediator of endothelial dysfunction-related microvascular diabetes complications. Thus, Cat-S or PAR2 inhibition might be a novel strategy to prevent microvascular disease in diabetes and other diseases.
Identifiers
PMID: 26567242
Full text
Article (Author postprint) (4.2 MB) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Analyse protéomique et Analyse génomique des maladies rénales (659)
Citation
(ISO format)
KUMAR VR, Santhosh et al. Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications. In: Journal of the American Society of Nephrology, 2016, vol. 27, n° 6, p. 1635-49. https://archive-ouverte.unige.ch/unige:84845

153 hits

0 download

Update

Deposited on : 2016-06-29

Export document
Format :
Citation style :